People

Noa Krawczyk
Noa Krawczyk, PhD
NYU Langone Health, Division of Epidemiology, Center for Opioid Epidemiology and Policy, Department of Population Health - Assistant Professor
Education
PhD, Mental Health, Johns Hopkins Bloomberg School of Public Health
BA, Biology, Hunter College at the City University of New York – Macaulay Honors College
Research Interests
Substance use, Opioids, Overdose, Health services, Mental health, Criminal justice, Treatment
BIO
Noa Krawczyk is an Assistant Professor in the Department of Population Health at NYU School of Medicine and a member of the Center for Opioid Epidemiology and Policy. She completed her PhD in the Department of Mental Health at the Johns Hopkins Bloomberg School of Public Health, where she studied substance use epidemiology, and previously worked as a Fulbright research scholar to study treatment and health services among cocaine users in Brazil. Her research focuses on studying ways to address barriers to evidence-based treatment for opioid use disorders and improving quality and effectiveness of care, especially among vulnerable groups such as persons with criminal justice involvement. Her work centers on bridging research and practice by collaborating with health organizations, public health and government agencies and advancing science that can help inform evidence-based policies and practices that reduce harm and promote long term recovery.
Publications

Recent

Krawczyk N, Bunting AM, Frank D, Arshonsky J, Gu Y, Friedman SR, Bragg MA (2021).
“How will I get my next week’s script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic
International Journal of Drug Policy, 92, 103140. doi: 10.1016/j.drugpo.2021.103140.

Bunting AM, Frank D, Arshonsky J, Bragg MA, Friedman SR, Krawczyk N (2021).
Socially-supportive norms and mutual aid of people who use opioids: An analysis of Reddit during the initial COVID-19 pandemic
Drug and Alcohol Dependence, 222, 108672. doi: 10.1016/j.drugalcdep.2021.108672. PMCID: PMC8057693.

Cerda M, Krawczyk N, Hamilton L, Rudolph KE, Friedman SR, Keyes KM (2021).
A critical review of the social and behavioral contributions to the overdose epidemic
Annual Review of Public Health, 42, 95-114. doi: 10.1146/annurev-publhealth-090419-102727.

Krawczyk N, Garrett B, Ahmad NJ, Patel E, Solomon K, Stuart EA, Saloner B (2021).
Medications for opioid use disorder among American Indians and Alaska natives: Availability and use across a national sample
Drug and Alcohol Dependence, 220, 108512. doi: 10.1016/j.drugalcdep.2021.108512.

Tofighi B, McNeely J, Walzer D, Fansiwala K, Demner A, Chaudhury CS, Subudhi I, Schatz D, Reed T, Krawczyk N (2021).
A telemedicine buprenorphine clinic to serve New York City: Initial evaluation of the NYC public hospital system’s initiative to expand treatment access during the COVID-19 pandemic
Journal of Addiction Medicine [Epub 2021 Feb 5]. doi: 10.1097/ADM.0000000000000809.


Notable

Krawczyk N, Buresh M, Gordon MS, Blue TR, Fingerhood MI, Agus D (2019).
Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap
Journal of Substance Abuse Treatment, 103, 1-8. doi: 10.1016/j.jsat.2019.05.002. PMCID: PMC6612429.

Krawczyk N, Picher CE, Feder KA, Saloner B (2017).
Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine
Health Affairs, 36 (12), 2046-2053. doi: 10.1377/hlthaff.2017.0890. PMCID: PMC6035729.

Dr. Krawczyk's MyBibliography Profile
Selected Press